AKTS — Aktis Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Aktis Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	129	97.9	297	227
Prepaid Expenses
Total Current Assets	132	100	301	230
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.87	20.9	20.9	27.2
Other Long Term Assets
Total Assets	138	122	326	265
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.28	6.24	18.8	31.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.5	18.6	80.6	77.6
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	131	104	246	187
Total Liabilities & Shareholders' Equity	138	122	326	265
Total Common Shares Outstanding